Moffitt Cancer Center
Last Modified: August 31, 2005
Conference Dates: November 17-19, 2005
Conference Location: Don CeSar Resort, St. Pete Beach, FL
Sponsoring Group: Moffitt Cancer Center
Conference Web Page URL: www.moffitt.usf.edu
Topics Covered: Clinical Problems in: Esophageal Cancer, Hepatobiliary Cancer, Pancreatic Cancer, Neuroendocrine Tumors, Colorectal Cancer
Conference Objectives: Understand the latest approach to management of difficult oncologic problems in patients with esophageal, rectal, pancreatic, liver, gallbladder and neuroendocrine cancers.
Who Should Attend: med oncs, gastroenterologists
Conference Agenda: Esophageal, Hepatobiliary Cancer and Pancreatic Cancer General Sessions; Neuroendocrine Tumors General Session; Colorectal Cancer General Session
Conference Fees: $295 MD's, $175 PA, RN
Continuing Education: Yes
Miscellany: CME: 14.5 hrs; ANCC 17.4 hrs.
May 24, 2012 - Regorafenib, an inhibitor of multiple cancer-associated kinases, is active in patients with metastatic gastrointestinal stromal tumors who have failed to respond to imatinib and sunitinib, according to a study published online May 21 in the Journal of Clinical Oncology.